Concepedia

Publication | Open Access

Cost-effectiveness of Prostate Cancer Screening: A Simulation Study Based on ERSPC Data

DOIFull Paper Access

160

Citations

40

References

2014

Year

Eveline A.M. Heijnsdijk, Tiago M. de Carvalho, Anssi Auvinen, Marco Zappa, Vera Nelen, Maciej Kwiatkowski, Arnauld Villers, Álvaro Páez, Sue Moss, Teuvo L.J. Tammela,
JNCI Journal of the National Cancer Institute

Abstract

Prostate cancer screening can be cost-effective when it is limited to two or three screens between ages 55 to 59 years. Screening above age 63 years is less cost-effective because of loss of QALYs because of overdiagnosis.

References

YearCitations

Page 1